Sharma, Ashish http://orcid.org/0000-0002-8550-9791
Parachuri, Nikulaa
Kumar, Nilesh http://orcid.org/0000-0002-7439-2081
Bandello, Francesco http://orcid.org/0000-0003-3238-9682
Kuppermann, Baruch D.
Article History
Received: 9 April 2022
Revised: 17 May 2022
Accepted: 18 May 2022
First Online: 26 May 2022
Competing interests
: Ashish Sharma: Consultant: for Novartis, Allergan, Bayer and Intas. Francesco Bandello: Consultant: Allergan, Bayer, Boehringer- Ingelheim, FidiaSooft, Hofmann La Roche, Novartis, NTC Pharma, Sifi, Thrombogenics, Zeiss. Baruch D Kuppermann: Clinical research: Alcon, Alimera, Allegro, Allergan, Apellis, Clearside, Genentech, GSK, Ionis, jCyte, Novartis, Regeneron, ThromboGenics; Consultant: Alimera, Allegro, Allergan, Cell Care, Dose, Eyedaptic, Galimedix, Genentech, Glaukos, Interface Biologics, jCyte, Novartis, Ophthotech, Regeneron, Revana, Theravance Biopharma. Nilesh Kumar: None. Nikulaa Parachuri: None.